Chemeq confirms details of $50m capital raising
Wednesday, 18 August, 2004
Chemeq (ASX: CMQ) has confirmed that its capital raising will include a placement of around AUD$10 million to institutions and sophisticated investors, as well as an underwritten rights offer of around $40 million to existing shareholders.
The placement is not likely to be completed until early next week, according to CEO Graham Melrose, and the rights issue will take another 3-4 weeks to complete. Shareholder approval is not required for the process.
Melrose said the placement price would be subject to a book building exercise, but would be likely to be in the region of $2.40-2.70.
The company is in voluntary suspension while it finalises the placement.
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...
